<?xml version='1.0' encoding='utf-8'?>
<document id="31230510"><sentence text="Effects of puerarin on the pharmacokinetics of triptolide in rats."><entity charOffset="11-19" id="DDI-PubMed.31230510.s1.e0" text="puerarin" /><entity charOffset="47-57" id="DDI-PubMed.31230510.s1.e1" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s1.e0" e2="DDI-PubMed.31230510.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s1.e0" e2="DDI-PubMed.31230510.s1.e1" /></sentence><sentence text="Context: Puerarin and triptolide are sometimes used together for the treatment of disease in Chinese clinics; however, the drug-drug interaction between puerarin and triptolide is still unknown"><entity charOffset="9-17" id="DDI-PubMed.31230510.s2.e0" text="Puerarin" /><entity charOffset="22-32" id="DDI-PubMed.31230510.s2.e1" text="triptolide" /><entity charOffset="153-161" id="DDI-PubMed.31230510.s2.e2" text="puerarin" /><entity charOffset="166-176" id="DDI-PubMed.31230510.s2.e3" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e0" e2="DDI-PubMed.31230510.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e0" e2="DDI-PubMed.31230510.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e0" e2="DDI-PubMed.31230510.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e0" e2="DDI-PubMed.31230510.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e1" e2="DDI-PubMed.31230510.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e1" e2="DDI-PubMed.31230510.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e1" e2="DDI-PubMed.31230510.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e2" e2="DDI-PubMed.31230510.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s2.e2" e2="DDI-PubMed.31230510.s2.e3" /></sentence><sentence text=" Objective: This study investigates the effects of puerarin on the pharmacokinetics of triptolide in rats and clarifies its main mechanism"><entity charOffset="51-59" id="DDI-PubMed.31230510.s3.e0" text="puerarin" /><entity charOffset="87-97" id="DDI-PubMed.31230510.s3.e1" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s3.e0" e2="DDI-PubMed.31230510.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s3.e0" e2="DDI-PubMed.31230510.s3.e1" /></sentence><sentence text=" Materials and methods: The pharmacokinetic profiles of oral administration of triptolide (1 mg/kg) in Sprague-Dawley rats with (test group, n = 6) or without pretreatment (control group, n = 6) with puerarin (100 mg/kg/day for seven days) were investigated"><entity charOffset="79-89" id="DDI-PubMed.31230510.s4.e0" text="triptolide" /><entity charOffset="200-208" id="DDI-PubMed.31230510.s4.e1" text="puerarin" /><pair ddi="false" e1="DDI-PubMed.31230510.s4.e0" e2="DDI-PubMed.31230510.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s4.e0" e2="DDI-PubMed.31230510.s4.e1" /></sentence><sentence text=" The effects of puerarin on the transport and metabolic stability of triptolide were also investigated using Caco-2 cell transwell model and rat liver microsomes"><entity charOffset="16-24" id="DDI-PubMed.31230510.s5.e0" text="puerarin" /><entity charOffset="69-79" id="DDI-PubMed.31230510.s5.e1" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s5.e0" e2="DDI-PubMed.31230510.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s5.e0" e2="DDI-PubMed.31230510.s5.e1" /></sentence><sentence text=" Results: The results showed that puerarin could significantly increase the peak plasma concentration (from 187"><entity charOffset="34-42" id="DDI-PubMed.31230510.s6.e0" text="puerarin" /></sentence><sentence text="25 ± 15" /><sentence text="36 to 219" /><sentence text="67 ± 21" /><sentence text="52 ng/mL), and decrease its oral clearance (from 4" /><sentence text="92 ± 0" /><sentence text="35 to 62" /><sentence text="46 ± 3" /><sentence text="75 ± 0" /><sentence text="19 L/h/kg)" /><sentence text=" The Caco-2 cell transwell experiments indicated that puerarin could decrease the efflux ratio of triptolide from 2"><entity charOffset="54-62" id="DDI-PubMed.31230510.s16.e0" text="puerarin" /><entity charOffset="98-108" id="DDI-PubMed.31230510.s16.e1" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s16.e0" e2="DDI-PubMed.31230510.s16.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s16.e0" e2="DDI-PubMed.31230510.s16.e1" /></sentence><sentence text="70 to 1" /><sentence text="33, and the intrinsic clearance rate of triptolide was decreased by the pretreatment with puerarin (38"><entity charOffset="40-50" id="DDI-PubMed.31230510.s18.e0" text="triptolide" /><entity charOffset="90-98" id="DDI-PubMed.31230510.s18.e1" text="puerarin" /><pair ddi="false" e1="DDI-PubMed.31230510.s18.e0" e2="DDI-PubMed.31230510.s18.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s18.e0" e2="DDI-PubMed.31230510.s18.e1" /></sentence><sentence text="8 ± 4" /><sentence text="7 vs" /><sentence text=" 32" /><sentence text="9 ± 6" /><sentence text="5 μL/min/mg protein)" /><sentence text=" Discussion and conclusions: Puerarin could significantly change the pharmacokinetic profiles of triptolide in rats, and it might exert these effects through increasing the absorption of triptolide by inhibiting the activity of P-gp, or through inhibiting the metabolism of triptolide in rat liver"><entity charOffset="29-37" id="DDI-PubMed.31230510.s24.e0" text="Puerarin" /><entity charOffset="97-107" id="DDI-PubMed.31230510.s24.e1" text="triptolide" /><entity charOffset="187-197" id="DDI-PubMed.31230510.s24.e2" text="triptolide" /><entity charOffset="274-284" id="DDI-PubMed.31230510.s24.e3" text="triptolide" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e0" e2="DDI-PubMed.31230510.s24.e0" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e0" e2="DDI-PubMed.31230510.s24.e1" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e0" e2="DDI-PubMed.31230510.s24.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e0" e2="DDI-PubMed.31230510.s24.e3" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e1" e2="DDI-PubMed.31230510.s24.e1" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e1" e2="DDI-PubMed.31230510.s24.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e1" e2="DDI-PubMed.31230510.s24.e3" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e2" e2="DDI-PubMed.31230510.s24.e2" /><pair ddi="false" e1="DDI-PubMed.31230510.s24.e2" e2="DDI-PubMed.31230510.s24.e3" /></sentence><sentence text=" The results also showed that the dose of triptolide should be decreased when these drugs were co-administered"><entity charOffset="42-52" id="DDI-PubMed.31230510.s25.e0" text="triptolide" /></sentence><sentence text="" /></document>